US Regulator Approves Gilead’s COVID Drug for Young Children

The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children age 28 days and older to Gilead Sciences Inc.'s drug remdesivir.

The move comes months after the agency expanded the drug's emergency use authorization to include children younger than 12 and weighing at least 3.5 kilograms.

The Food and Drug Administration's (FDA) decision makes the drug the first approved COVID-19 treatment for children under 12 years old, the agency said.

The approval is applicable to children who are hospitalized or have mild-to-moderate disease and are at high risk of severe COVID-19.

Source: Voice of America

Releated

1955 Mercedes Sells For Record $143 Million: Sotheby’s

A 1955 Mercedes-Benz, one of only two such versions in existence, was auctioned off earlier this month for a whopping $143 million, making it the world’s most expensive car ever sold, RM Sotheby’s announced Thursday.The 300 SLR Uhlenhaut Coupe was sold…

African Scientists Baffled by Monkeypox Cases in Europe, US

Scientists who have monitored numerous outbreaks of monkeypox in Africa say they are baffled by the disease’s recent spread in Europe and North America.Cases of the smallpox-related disease have previously been seen only among people with links to cent…